Connect with us

Health

Child deaths in Gambia linked to cough syrups made in India – WHO

Published

on

The deaths of dozens of young children in Gambia from acute kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday.

The findings, announced by WHO Director-General Tedros Adhanom Ghebreyesus, followed tests on several medicinal syrups that were suspected of causing 66 child deaths in the tiny West African country.

Tedros told reporters that the U.N. agency was conducting an investigation with Indian regulators and the company that made the syrups, New Delhi-based Maiden Pharmaceuticals Ltd.

Maiden Pharma declined to comment, while calls and messages to the Drugs Controller General of India went unanswered. India’s health ministry did not respond to a request for comment, Reuters reported.

According to Reuters the WHO issued a medical product alert on Wednesday asking regulators to remove Maiden Pharma goods from the market.

The products may have been distributed elsewhere through informal markets, but had so far been identified only in Gambia, the WHO said in its alert.

The alert covers four products: Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup, read the report.

Lab analysis confirmed “unacceptable” amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury, the WHO said.

Medical officers in Gambia raised the alarm in July, after dozens of children began falling ill with kidney problems. The deaths confounded medics before a pattern emerged: dozens of patients younger than five were falling ill three to five days after taking a locally sold paracetamol syrup.

Gambia’s director of health services, Mustapha Bittaye, said similar problems have been detected in other syrups but that the ministry is awaiting confirmation of the results, Reuters reported.

He said the number of deaths has tapered off in recent weeks and that the sale of products made by Maiden Pharmaceuticals was banned. However, until recently, some of the syrups were still being sold in private clinics and in hospitals, he said.

Gambia’s Medicines Control Agency sent a letter on Tuesday to health professionals ordering them to stop selling any of the products listed by WHO.

Maiden Pharmaceuticals manufactures medicines at its facilities in India, which it then sells domestically as well as exporting them to countries in Asia, Africa and Latin America, according to its website.

Health

Afghan delegation heads to Turkey for medicine talks

Published

on

Naemullah Ayoubi, Director General of Drug and Health Products Regulation at Afghanistan’s Ministry of Public Health, has departed for Turkey on an official visit accompanied by a technical delegation.

The Ministry of Public Health said the delegation will hold meetings with officials from Turkey’s pharmaceutical regulatory authority and discuss a number of key issues related to the regulation of medicines and health products.

The delegation is also scheduled to visit several pharmaceutical manufacturing factories in Turkey.

According to the ministry, the visit aims to strengthen coordination between the two countries in the production and import of medicines, in order to ensure the availability of high-quality and affordable pharmaceuticals for people in Afghanistan in both the short and long term.

Continue Reading

Health

Afghanistan opens first national cancer diagnosis and treatment hospital

Published

on

The Ministry of Public Health announced on Thursday that Afghanistan has inaugurated its first national hospital dedicated to the diagnosis and treatment of cancer, marking a major step forward in the country’s healthcare services.

The facility, named the National Cancer Diagnostic and Therapeutic Hospital, has officially begun operations and will provide specialized care for cancer patients across the country.

Speaking at the inauguration ceremony, Public Health Minister Noor Jalal Jalali said the 200-bed hospital aims to offer hope and improved treatment options for patients suffering from cancer.

“Fortunately, we are jointly opening a 200-bed hospital for cancer patients, and we hope that this hospital will become a source of hope and healing for those in need,” Jalali said.

The minister added that specialized training programs will soon be launched at the hospital to educate and train domestic medical specialists. He noted that reforms have already been implemented to improve facilities and ensure better healthcare services.

Jalali also emphasized international cooperation in the project, saying that radiotherapy services will be introduced at the hospital with support from India. According to the ministry, India has so far provided $1 million in assistance, including 10 tons of medicines and medical equipment, to support cancer treatment in Afghanistan.

The opening of the hospital is expected to reduce the need for Afghan patients to seek costly cancer treatment abroad and improve access to specialized care inside the country.

Continue Reading

Health

Pakistan becomes latest Asian country to introduce checks for deadly Nipah virus

Published

on

Authorities in Pakistan have ordered enhanced screening of people entering the country for signs of infections of the deadly Nipah virus after India confirmed two cases, adding to the number of Asian countries stepping up controls.

Thailand, Singapore, Hong Kong, Malaysia, Indonesia and Vietnam have also tightened screening at airports, Reuters reported.

The Nipah virus can cause fever and brain inflammation and has a high mortality rate. There is also no vaccine. But transmission from person to person is not easy and typically requires prolonged contact with an infected individual.

“It has become imperative to strengthen preventative and surveillance measures at Pakistan’s borders,” the Border Health Services department said in a statement.

“All travelers shall undergo thermal screening and clinical assessment at the Point of Entry,” which includes seaports, land borders and airports, the department added.

The agency said travellers would need to provide transit history for the preceding 21-day period to check whether they had been through “Nipah-affected or high-risk regions”.

There are no direct flights between Pakistan and India and travel between the two countries is extremely limited, particularly since their worst fighting in decades in May last year.

In Hanoi, the Vietnamese capital’s health department on Wednesday also ordered the screening of incoming passengers at Noi Bai airport, particularly those arriving from India and the eastern state of West Bengal, where the two health workers were confirmed to have the virus in late December.

Passengers will be checked with body temperature scanners to detect suspected cases. “This allows for timely isolation, epidemiological investigation,” the department said in a statement.

That follows measures by authorities in Ho Chi Minh City, Vietnam’s largest city, who said they had tightened health controls at international border crossings.

India’s health ministry said this week that authorities have identified and traced 196 contacts linked to the two cases with none showing symptoms and all testing negative for the virus.

Nipah is a rare viral infection that spreads largely from infected animals, mainly fruit bats, to humans. It can be asymptomatic but it is often very dangerous, with a case fatality rate of 40% to 75%, depending on the local healthcare system’s capacity for detection and management, according to the World Health Organization.

The virus was first identified just over 25 years ago during an outbreak among pig farmers in Malaysia and Singapore, although scientists believe it has circulated in flying foxes, or fruit bats, for thousands of years.

The WHO classifies Nipah as a priority pathogen. India regularly reports sporadic infections, particularly in the southern state of Kerala, regarded as one of the world’s highest-risk regions for Nipah.

As of December 2025, there have been 750 confirmed Nipah infections globally, with 415 deaths, according to the Coalition for Epidemic Preparedness Innovations, which is funding a vaccine trial to help stop Nipah.

Continue Reading

Trending

Copyright © 2025 Ariana News. All rights reserved!